...
首页> 外文期刊>Molecular & Cellular Toxicology >Sensitizing effect of silencing Ape1/Ref-1 on doxorubicin-induced apoptosis in human carcinoma cells
【24h】

Sensitizing effect of silencing Ape1/Ref-1 on doxorubicin-induced apoptosis in human carcinoma cells

机译:沉默Ape1 / Ref-1对阿霉素诱导人癌细胞凋亡的增敏作用

获取原文
           

摘要

Ape1/Ref-1 is a multifunctional protein with major functions in DNA base excision repair system and redox regulation of several transcription factors. However, overexpression of Ape1/Ref-1 is observed in many types of malignant cancers, leading to point that this protein might be a molecular candidate for anticancer drug treatment. A doxorubicin (DOX) has been widely applied in the chemotherapy of solid tumors including lung. Cytotoxification of DOX is targeting on damage to cellular components, particularly DNA molecules, via generation of reactive oxygen species (ROS). Using specific suppression by short hairpin RNA (shRNA)-based viral vector, an important role of Ape1/Ref-1 on DOX resistance in human lung cancer H1299 cell was investigated in this study. Our data revealed that the stable Ape1/Ref-1 shRNA knockdown had higher susceptibility to DOX compared to the wild type. In accordance, intracellular ROS level was notably accelerated in the Ape1/Ref-1 shRNA defect rather than the wild type. Strikingly, our observation represented that in presence of DOX Ape1/Ref-1 deficiency probably stimulated double strand breaks to DNA, detected by neutral comet assay and gamma-H2AX immunoassay, sensitive methods of genotoxicity. Furthermore, our result showed that DOX-induced apoptosis was also correlated with increase in oxygen radicals-generated damage to DNA. We can conclude that Ape1/Ref1-targeted silencing via shRNA-based interference might be a promising molecular strategy to improve effectiveness of DOX-induced apoptosis in treatment of human lung cancer cells, through induction of oxidative insult. This emphasizes that Ape1/Ref-1 might be a prominent therapeutic target in cancer therapy.
机译:Ape1 / Ref-1是一种多功能蛋白,在DNA碱基切除修复系统和某些转录因子的氧化还原调节中具有主要功能。但是,在许多类型的恶性肿瘤中都观察到Ape1 / Ref-1的过度表达,这表明该蛋白可能是抗癌药物治疗的分子候选物。阿霉素(DOX)已广泛应用于包括肺在内的实体瘤的化学疗法中。 DOX的细胞毒化作用是通过产生活性氧(ROS)来破坏细胞成分,特别是DNA分子。使用基于短发夹RNA(shRNA)的病毒载体的特异性抑制,本研究研究了Ape1 / Ref-1在人肺癌H1299细胞中对DOX耐药性的重要作用。我们的数据显示,与野生型相比,稳定的Ape1 / Ref-1 shRNA敲除对DOX的敏感性更高。因此,在Ape1 / Ref-1 shRNA缺陷而非野生型中,细胞内ROS水平显着提高。令人惊讶的是,我们的观察结果表明,在缺乏DOX Ape1 / Ref-1的情况下,可能会通过中性彗星测定法和γ-H2AX免疫测定法(遗传毒性的敏感方法)检测到DNA的双链断裂。此外,我们的结果表明,DOX诱导的细胞凋亡也与氧自由基对DNA的损伤增加有关。我们可以得出结论,通过基于shRNA的干扰使Ape1 / Ref1靶向沉默可能是一种有前途的分子策略,可通过诱导氧化损伤来提高DOX诱导的人肺癌细胞凋亡的治疗效果。这强调了Ape1 / Ref-1可能是癌症治疗中的重要治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号